Cargando…
Drug target gene-based analyses of drug repositionability in rare and intractable diseases
Drug development for rare and intractable diseases has been challenging for decades due to the low prevalence and insufficient information on these diseases. Drug repositioning is increasingly being used as a promising option in drug development. We aimed to analyze the trend of drug repositioning a...
Autores principales: | Sakate, Ryuichi, Kimura, Tomonori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196006/ https://www.ncbi.nlm.nih.gov/pubmed/34117295 http://dx.doi.org/10.1038/s41598-021-91428-4 |
Ejemplares similares
-
A novel in silico scaffold-hopping method for drug repositioning in rare and intractable diseases
por: Tanabe, Mao, et al.
Publicado: (2023) -
Artificial intelligence-based computational framework for drug-target prioritization and inference of novel repositionable drugs for Alzheimer’s disease
por: Tsuji, Shingo, et al.
Publicado: (2021) -
FDA Approved Drug Library Screening Identifies Robenidine as a Repositionable Antifungal
por: Mei, Yikun, et al.
Publicado: (2020) -
Trends of Clinical Trials for Drug Development in Rare Diseases
por: Sakate, Ryuichi, et al.
Publicado: (2018) -
Pitfalls in TAMVI: experience with the repositionable Lotus® Valve System
por: Heinisch, Paul P., et al.
Publicado: (2017)